KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to $29.7 million.

  • Fulgent Genetics' Net Cash Flow rose 51948.95% to $29.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.7 million, marking a year-over-year increase of 32854.57%. This contributed to the annual value of -$42.1 million for FY2024, which is 33260.65% down from last year.
  • Fulgent Genetics' Net Cash Flow amounted to $29.7 million in Q3 2025, which was up 51948.95% from $20.6 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Net Cash Flow ranged from a high of $188.2 million in Q1 2022 and a low of -$213.7 million during Q2 2022
  • In the last 5 years, Fulgent Genetics' Net Cash Flow had a median value of $10.4 million in 2024 and averaged $1.6 million.
  • The largest annual percentage gain for Fulgent Genetics' Net Cash Flow in the last 5 years was 250733.08% (2021), contrasted with its biggest fall of 64204.86% (2021).
  • Quarter analysis of 5 years shows Fulgent Genetics' Net Cash Flow stood at -$50.0 million in 2021, then plummeted by 77.9% to -$89.0 million in 2022, then skyrocketed by 114.89% to $13.3 million in 2023, then plummeted by 120.86% to -$2.8 million in 2024, then soared by 1176.19% to $29.7 million in 2025.
  • Its Net Cash Flow was $29.7 million in Q3 2025, compared to $20.6 million in Q2 2025 and $12.1 million in Q1 2025.